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AbstrACt
Introduction Emergency department (ED) visits 
for epilepsy are common, costly, often clinically 
unnecessary and typically lead to little benefit for 
epilepsy management. An ‘Alternative Care Pathway’ 
(ACP) for epilepsy, which diverts people with epilepsy 
(PWE) away from ED when ‘999’ is called and leads to 
care elsewhere, might generate savings and facilitate 
improved ambulatory care. It is unknown though what 
features it should incorporate to make it acceptable 
to persons from this particularly vulnerable target 
population. It also needs to be National Health Service 
(NHS) feasible. This project seeks to identify the optimal 
ACP configuration.
Methods and analysis Mixed- methods project 
comprising three- linked stages. In Stage 1, NHS bodies 
will be surveyed on ACPs they are considering and semi- 
structured interviews with PWE and their carers will 
explore attributes of care important to them and their 
concerns and expectations regarding ACPs. In Stage 2, 
Discrete Choice Experiments (DCE) will be completed 
with PWE and carers to identify the relative importance 
placed on different care attributes under common 
seizure scenarios and the trade- offs people are willing 
to make. The uptake of different ACP configurations 
will be estimated. In Stage 3, two Knowledge Exchange 
workshops using a nominal group technique will be run. 
NHS managers, health professionals, commissioners 
and patient and carer representatives will discuss 
DCE results and form a consensus on which ACP 
configuration best meets users’ needs and is NHS 
feasible.
Ethics and dissemination Ethical approval: NRES 
Committee (19/WM/0012) and King’s College London 
ethics Committee (LRS-18/19-10353). Primary output 
will be identification of optimal ACP configuration which 
should be prioritised for implementation and evaluation. 
A pro- active dissemination strategy will make those 
considering developing or supporting an epilepsy ACP 
aware of the project and opportunities to take part in it. 
It will also ensure they are informed of its findings.
Project registration number Researchregistry4723.
IntroduCtIon
Context and drive for health service innovations
The National Health Service (NHS), like 
other health systems, is being asked to make 
cost savings, while improving care experi-
ence, outcomes and reducing health inequali-
ties.1 2 Emergency department (ED) visits and 
admissions for the ambulatory care sensitive 
condition epilepsy provide an opportunity 
where service innovations could help achieve 
such aims. We describe a mixed- methods 
project to maximise the likelihood of such 
innovations being beneficial to service users 
and society.
strengths and limitations of this study
 ► Project seeks to identify the optimal configuration 
of an ‘Alternative Care Pathway’ for epilepsy which 
could minimise clinically unnecessary and/or avoid-
able unplanned health service use and facilitate im-
proved outcomes.
 ► The novel co- production approach employed—
which will involve stakeholders at each project stage 
and use Discrete Choice Experiments (DCE)—will 
allow service users to inform service design in a sci-
entifically robust, non- tokenistic way and could pro-
vide a template for service design more generally.
 ► Whilst most of the work packages will involve stake-
holders from across England, patient and carers for 
the DCE are being recruited from one region. This 
might limit generalisability.
 ► The ACP configuration identified will be developed 
for use in the NHS and so may not be immediately 
applicable to other health systems. It will also re-
quire evaluation via a subsequent project.
 ► The project’s success will depend, in part, on service 
users from what is a particularly vulnerable popula-
tion agreeing to participate and representative sam-
ples being generated.
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Epilepsy and unplanned service use
With a prevalence of ~1%,3 epilepsy is the UK’s second most 
common serious neurological disorder. Annually, ≤20% of 
people with epilepsy (PWE) visit hospital ED.4–6 They report 
more anxiety, seizures and perceived epilepsy stigma than 
those in the wider epilepsy population and live in more 
deprived areas7–12; ~20% have an intellectual disability.13 14
The annual cost to the NHS of these visits in England 
alone is ~£70–90M.15–17 Costs are high because half of the 
visits result in hospital admission.6 18–21 An unusually high 
re- attendance rate also inflates cost22 23;≤60% of PWE 
re- attend ED within 12 months.7
Most PWE visiting ED do not attend with a life threat-
ening or emergency presentation, (eg, status epilepticus, 
first seizure). Rather, projects like our National Audits of 
Seizure Management in Hospitals (NASH)13 14 show that 
most have known, rather than new epilepsy, and present 
with states not requiring ED’s full facilities. Leading 
presentations include someone who has experienced: 
(i) an uncomplicated seizure in line with their usual 
presentation; (ii) a seizure in public and cannot be ‘left 
at scene’; and (iii) a self- terminating seizure, different to 
their usual presentation.20
unmet needs of PWE visiting Ed
While the acute episodes leading PWE to visit ED do not 
typically require emergency care, the visits can be expres-
sions of the person having received suboptimal ambulatory 
care and unmet needs. NASH19, for instance, found that 
most (~65%) PWE visiting ED are not known to specialist 
epilepsy services and many were via their usual care 
provider, seemingly receiving outdated care. For instance, 
despite focal epilepsy being the most common epilepsy 
type, most likely to be refractory and often not best treated 
with the medication sodium valproate, NASH found it to be 
the most prescribed medication among ED attendees.
Coping with life in the context of epilepsy also requires 
an individual to accept their diagnosis and learn and adopt 
a range of self- management behaviours to prevent seizures 
and manage consequences. PWE visiting ED though and 
their significant others appear to have less knowledge 
about epilepsy and its management, including seizure first 
aid.7 24–26 They might therefore benefit from enhanced self- 
management support, like that provided by epilepsy nurses. 
The reason that knowledge might be low in ED attendees is 
because there remains no routine course that all PWE can 
go on to learn about epilepsy (as there are for some condi-
tions). People who have lower education levels appear to 
fare worst from this situation with them having been found 
to have the least epilepsy knowledge.27 28
That some PWE in the UK are receiving suboptimal 
care is well known, with there being longstanding chal-
lenges in ensuring that the PWE most in need of specialist 
care receive it. While trial evidence indicates ~70% of 
PWE can become seizure free, some evidence indicates 
only ~50% of PWE in the UK currently are,29 with PWE in 
socially deprived areas faring the worst.30 Factors contrib-
uting to the challenge are that the UK has a comparatively 
small specialist workforce31 and that there is no national, 
incentivised system to identify those within the epilepsy 
population that might need stepped- up care. To further 
complicate matters, General Practitioners (GPs), who 
care for most PWE, have expressed low confidence in 
managing the condition.
ED visits by PWE can be considered opportunities to 
intervene. Unfortunately, under current arrangements, 
going to ED does not typically lead to PWE receiving ambu-
latory care improvements. Bodies, such as The National 
Institute for Health and Care Excellence (NICE)2, recom-
mend that when seizures are not controlled, a patient 
should be referred to specialist services (within 4 weeks) 
since this may improve outcomes, including rendering 
some seizure free.32 33 Most (80%) PWE visiting ED are 
though not seen by a specialist during their attendance, 
their usual care providers may not be informed of the 
attendance13 and most (60%) are not referred to a 
specialist for follow- up.
PWE living in the most deprived areas, as well as the 
elderly, are among the least likely to be referred on from 
ED.34 The low referral rate may be due to some clinicians 
holding an incorrect nihilistic view that intractability is 
inevitable if seizure control is not obtained within a few 
years of therapy onset. Assumptions about the willingness 
of certain patient groups to attend clinics may also be 
being made.35 36
An ‘Alternative Care Pathway’
NHS policies1 2 37 and publicity given to NASH’s find-
ings15 38 created momentum to reduce visits for seizures 
and enhance patient outcomes. NICE39 found no evidence 
on how to do this. However, one idea gaining traction is 
for ambulance services to assume a greater role.40 Most 
(~90%) people visiting ED for seizures have been trans-
ported there by an emergency ambulance.13 14 21
Data from some regional ambulance services on convey-
ance rates for seizures has been published. It indicates 
ambulance staff are recommending conveyance of nearly 
every person they attend for a suspected seizure to ED,41–43 
despite most not demonstrating a clinical need (eg, seizures 
have self- terminated before ambulance arrival in ~90% of 
cases),42 One reason for this is paramedics lack access to 
alternatives.44–46 There is a vision therefore of what could 
help: ambulance service access to some form of ‘Alterna-
tive Care Pathway’ (ACP) whereby those seeking help for 
an epileptic seizures judged not to require ED are cared for 
within less costly, alternative environments.
The exact nature of the ACP is not clear. Different 
regions and services are considering different configura-
tions and doing so in an uncoordinated way. ACPs being 
considered appear to include paramedics transporting 
patients’ home or to an urgent treatment centre rather 
than ED. Others involve paramedics leaving patients at 
scene with the offer of a telephone call from a nurse or 
general practitioner with a specialist interest in epilepsy 
within 24, 48 or 72 hours. A possible benefit of this latter 
configuration is health inequalities could be reduced by 
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introducing a mechanism by which all PWE ‘in need’ are 
brought to specialists’ attention.
ACPs are not new47 and paramedics have not been 
obliged to transport patients to ED since ~1997. The 
ambitions of ACPs have though increased and there is 
significant support within the UK policy realm to expand 
the number of conditions covered by them as a means of 
managing demands on hospital services.48–50
ACPs within the ambulance have largely come about due 
to the ‘it seemed like a good idea at the time’ principle,51 
rather than with reference to a behaviour change theory. 
Evidence on the utility of ACPs is though generally posi-
tive.47 52–54 In their review of potential revisions to the urgent 
and emergency care system, the Nuffield Trust identified 
greater ambulance/paramedic triage in the community 
as having the most the positive evidence of effectiveness.40 
Paramedics appear willing and safely able to use ACPs when 
trained and for some ACPs there is evidence of cost- savings 
and greater patient satisfaction.52 53
In the case of epilepsy, qualitative research44–46 provides 
the beginnings of a theoretical basis for the use of an ACP 
in epilepsy with the mechanisms by which it could make 
a difference being that it may: increase awareness and 
likelihood that paramedics will consider non- conveyance 
and referral pathways as an option in appropriate cases; 
increase paramedics’ clinical knowledge of how to make 
appropriate non- conveyance decisions; increase para-
medics’ knowledge of alternative care providers that are 
acceptable to service users; and increase paramedics’ 
confidence about making a non- conveyance decision and 
reducing anxiety about risk.
developing an ACP for epilepsy
An ACP for epilepsy holds potential. As a team of health-
care professionals, researchers and service user repre-
sentatives with expertise in epilepsy and urgent care, our 
ultimate goal is therefore to evaluate the most promising 
ACP and use the evidence to transform service organi-
sation nationally. However, we cannot currently do this 
because the way in which ACPs are being developed 
means it is not known which of the ACPs has the potential 
to be most effective and could be justified for selection.
Specifically, ACPs are being developed largely ‘top- down’, 
with the patient voice being absent. The nature and content 
of ACPs may not therefore align with what patients/carers 
would consider to meet their needs. Evidence suggests 
decisions to access healthcare services can be informed by 
how a patient/carer perceives their situation55–57 and there 
can be a mismatch between patients/carers and health 
professionals’ views, including of what constitutes an ‘emer-
gency’.58–61 The upshot is the acceptability—a fundamental 
criterion an intervention needs to satisfy to be positioned to 
achieve its intended outcome51—of the different ACPs to 
patients and carers is unknown.
To date, only one epilepsy ACP has been reported on.62 
Despite the evaluation revealing positive outcomes, less 
than 10% of eligible PWE attended to by paramedics were 
put onto the ACP. The reasons for this low uptake rate 
were not explored. A possible explanation is that the ACP 
was not acceptable to PWE.
It has been assumed the target population does not want 
to be conveyed to ED and will readily accept an ACP. It 
may not be that straightforward. Some PWE certainly 
express dissatisfaction with being taken to ED.63 Others 
though express a need for immediate access to urgent 
care; with some PWE and their family and friends (to 
whom care decisions are often delegated to when the 
patient is unconscious or lacks capacity) being fearful of 
seizures, including the possibility of brain damage.25 26
CurrEnt ProjECt
This 28 month project seeks to identify the ACP that 
should be prioritised for testing/implementation. It 
seeks to shape the change that results from the identified 
momentum so the likelihood of patients and the NHS 
benefiting are maximised and finite health resources used 
in an informed, rational way. It will bring patients/carers 
from the target population, healthcare professionals and 
commissioners together to identify which ACP configura-
tion best encapsulates the features important to patients 
and carers and is feasible within the NHS context. The 
focus will be on the care of adults with epilepsy, rather than 
children/young people, since discussion to date relating 
to the use of ACPs and ED care has largely focused on the 
former (eg,.19 62). As per NICE guidelines for epilepsy,39 
adults are defined as those aged 18 years and older.
The project has three linked stages and will use survey 
techniques, qualitative methods, consensus meetings 
and Discrete Choice Experiments (DCEs) to achieve its 
aims (figure 1).64 65 DCEs are an attribute- based survey 
methodology, underpinned by the theory that any ‘good’ 
(including a health service) can be described by its constit-
uent characteristics (attributes), and that the extent to 
which an individual prefers a ‘good’ depends on the levels 
these attributes take.66 We considered DCEs to provide an 
efficient, scientifically defensible, and non- tokenistic way 
of bringing the patient voice into ACP design since they 
allow a person’s stated preferences and priorities to be 
elicited by presenting them with a hypothetical scenario 
(eg, having a seizure at home) and asking them to choose 
which of two (or more) care options described by a series 
of attributes they prefer. The process is then repeated 
with alternative care choices being presented. By varying 
attribute levels and observing how participants change 
responses, the importance of attributes and the extent to 
which they drive preference can be inferred.
Aims
a. Systematically identify ACPs being considered by the 
NHS for epilepsy and describe extent to which service 
users have been involved in their design (Stage 1a).
b. Understand patient and carers’ decision- making pro-
cesses for seeking or not seeking ED care, and their 
concerns and expectations regarding ACPs (Stage 1b).
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Figure 1 Research project process diagram. ACP/s, alternative care pathway/s; DCEs, Discrete Choice Experiments; EDS, 
Emergency Departments; GP, General Practitioner; HRA, health research authority; NHS, National Health Service; PICs, 
Participant Identification Centres; PWE, People with Epilepsy.
c. Identify the attributes of post- seizure emergency care 
that PWE and their carers consider important and 
identify if this differs by the context in which the sei-
zure occurs (Stage 1b).
d. Determine patient and carer preferences for post- 
seizure emergency care using DCEs and identify any 
subgroup differences (Stage 2b).
e. Estimate uptake of different ACPs configurations by 
patients and subgroup differences (Stage 2b).
f. Hold expert workshops to develop an optimal ACP fol-
lowing seizures, to be prioritised for implementation 
and evaluation via a subsequent project (Stage 3).
MEthods And AnAlysIs
This project will use qualitative and quantitative methods 
(figure 1). According to Greene et al’s67 conceptual frame-
work, the purpose of using a mixed methods approach is 
‘development’ (seeking to use the results from one method 
to help develop or inform the other method, where devel-
opment is broadly construed to include sampling and 
implementation, as well as measurement decisions; Stages 
1–2b) and ‘expansion’ (seeking to extend the breadth and 
range of inquiry by using different methods for different 
inquiry components; Stages 2b and 3).
Data collection and analysis for Stages 1a and 1b will 
be completed concurrently and independent from one 
another. From Stage 1 c onwards, the design will be 
sequential and dependent. During Stage 2a, the findings 
from the earlier stages will be integrated to develop the 
DCE. Following completion of analysis for Stage 3, find-
ings from all the stages will be integrated in a narrative 
form when interpreting and reporting on the project’s 
findings. Particular attention will be given to how the find-
ings from Stage 3 converge and diverge from the qualita-
tive and quantitative findings from the earlier stages.
stage 1
Stage 1a: pathway survey
Purpose
Systematically identify ACPs being considered. Will allow 
ACPs presented within DCEs to include main ones being 
considered.
Design
Cross- sectional survey of NHS service providers asking 
respondents whether their service has considered (or 
implemented) any changes to the management of those 
with epilepsy/suspected seizures to minimise clinically 
unnecessary/avoidable ED visits. Respondents will report 
how change is anticipated to minimise visits and whether 
service users informed change.
The survey will take ~10 min, be piloted and completed 
online. Survey respondents will be able to indicate if they 
want to be informed of subsequent project parts.
Recruitment
Invitations to participate, followed by two reminders, 
will be sent to clinical leads/directors of England’s 
regional ambulance trusts (n=11), regional neurosci-
ence (~n=25)68 and neurology centres (~n=16),69 70 and a 
random sample of 25% of its ‘Type 1’ EDs71 (n=35), strati-
fied by geographical area and size (attendances).
Analysis
Characteristics of responding and non- responding organ-
isations will be compared. To determine the types of ACPs 
being considered and proportion of organisations consid-
ering each, a subset of surveys will be selected. A quali-
tative researcher, supported by the wider team, will read 
these to identify recurrent ACP types and collate them 
into a thematic coding framework. The framework will 
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be applied to the full data set and modified to ensure all 
ACPs types are captured.
Stage 1b: qualitative interviews
Purpose
Understand patient and carer decision- making, the 
important attributes of post- seizure care, and concerns 
and expectations regarding ACPs. Will permit attribute 
development to adhere to good practice.72 73
Design
Face- to- face semi- structured interviews will be conducted 
with PWE, and where possible an informal carer, and 
shaped by a piloted topic guide (online supplementary 
file 1).
Participants will be asked for contextual information 
about their epilepsy and ED visits. The researcher will 
explore patients and carers confidence in managing seizures 
and the decision to call the ambulance services. The influ-
ences on ambulance use and ED use when seizures occur in 
public places will also be examined. Evaluative information 
will then be sought regarding positive and negative percep-
tions of the ambulance service and casualty as well as any 
ACPs experienced. Potential attributes will be identified by 
describing two known ACPs (ie, urgent care centres and 
being taken home) and asking participants for their expec-
tations and concerns.
To help reduce the number of care attributes and 
improve face validity, participants will rank what they 
consider to be the five most important care attributes. 
Interviewer will help recall those mentioned and write 
them onto show cards.
To promote consistency, interviews will be conducted 
by one experienced qualitative researcher (AMK). AMK 
(PhD), is a university- based qualitative researcher with an 
interest in health services research but no specialist knowl-
edge of, or involvement in, the ambulance or emergency 
medical services. Before agreeing to take part, participants 
will be given a participant information sheet detailing the 
research. Written informed consent will be obtained (by 
AMK) before the interviews. No non- participants will be 
present during the interviews. Interviews will take place at 
a time and place convenient to the participant. It is antici-
pated they will last 60–90 min.
To promote transparency, meticulous records of the 
interviews will be kept, interviews audio- taped, tran-
scribed verbatim74 and reported according to Consoli-
dated criteria for Reporting Qualitative research.75
Recruitment
Aim is to capture a comprehensive range of perspectives, 
and sample size will be determined by data saturation. We 
anticipate72 76 recruiting a purposive sample of ~30 PWE, 
with or without an informal carer. Table 1 lists the inclu-
sion and exclusion criteria.
Eligible PWE will be identified by two means. First, persons 
with uncontrolled epilepsy who participated in a recent 
National Institute for Health Research (NIHR) funded 
‘Self- Management Education for adults with Epilepsy’ trial 
in the South- East of England and expressed interest in 
future projects will sent notification of the study.77 Second, 
adverts will be circulated to persons affiliated with epilepsy 
user groups, including Epilepsy Action. Persons interested 
in taking part will be asked to contact the research team. To 
identify carer participants, patients will be asked to choose 
a significant other/informal carer to take part. Participants 
will receive a £20 shopping voucher.
Analysis
Analysis will proceed alongside data collection and be 
based on a Framework approach.78 This approach ensures 
each case is fully accounted for and is regarded as particu-
larly helpful for addressing policy questions. The primary 
aim of analysis will be to generate an exhaustive list and 
description of the salient attributes of care (and levels) 
identified by participants.
The analytic approach will involve the identification of 
initial themes that are then grouped into main themes 
and subthemes. Transcripts will be read and re- read, and 
coded. At least two members of the research team (AMK, 
MM, LR) will participate in all data analysis to reduce bias 
in the identification and interpretation of themes.
A thematic ‘chart’ will be created to summarise infor-
mation for each theme to allow cross‐case and within‐case 
analysis through a process of constant comparison, with 
particular attention being paid to deviant cases. Anal-
ysis will pay attention to the similarity and differences in 
salient attributes according to where the seizure occurred 
(home, public), who was there, who made the 999 call, 
whether the patient had seen a specialist in the prior 12 
months, and whether they self- reported an intellectual 
impairment. Participant quotations (with minor editing 
where necessary to preserve anonymity) will be presented 
to illustrate themes and help verify interpretation. QSR 
International’s NVivo 11 qualitative data analysis soft-
ware79 will be used as a management tool throughout the 
process.
The attributes nominated during the ranking exercise 
will be categorised according to the thematic framework, 
then analysed quantitatively (by EAH) using standardised 
rank scores.
Stage 1c: knowledge exchange event
Purpose
It is important the DCE elicits views on ACPs that could 
plausibly be delivered within the NHS. This event will 
therefore, early in the project, determine feasibility of the 
attributes and associated levels that have been identified 
by service users in Stage 1b.
Design
One- day event at which healthcare professional represen-
tatives will be shown draft attributes, levels, and choice 
sets and asked to deliberate each choice. For instance, 
should Stage 1b indicate service users consistently say 
they prefer to be transported home by the ambulance 
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Table 1 Participant inclusion and exclusion criteria
Study part Inclusion criteria Exclusion criteria
Stage 1b—Qualitative interviews
 ► Established diagnosis of epilepsy, or an informal carer for 
someone with epilepsy
 ► Age≥18 years (no upper age limit)
 ► Have visited ED in the past 12 months for epilepsy (as 
reported by the patient)*
 ► Able to provide informed consent and communicate in 
English
 ► Severe current psychiatric disorders 
(eg, acute psychosis)
 ► Life- threatening medical illness
Stage 2—Discrete choice experiments
Group 1
Patients  ► Clinically confirmed diagnosis of epilepsy (for any duration)
 ► Any epilepsy syndrome and any types of focal or generalised 
seizures
 ► Currently being prescribed antiepileptic medication
 ► Age≥18 years (no upper age limit)
 ► Have visited ED in the past 12 months for epilepsy
 ► Able to provide informed consent and independently 
complete a questionnaire in English
 ► Lives in the North West of England
 ► Severe current psychiatric disorders 
(eg, acute psychosis)
 ► Life- threatening medical illness
 ► Resides within a care or nursing home 
or of no fixed abode
Carers
 ► A significant other to a person with epilepsy (eg, family 
member, friend) who the patient identifies as providing 
informal support or self- identifies themselves if the patient 
has a substantial intellectual disability
 ► The person with epilepsy they care for has visited ED in the 
past 12 months
 ► Age≥16 years (no upper age limit)
 ► Able to provide informed consent and independently 
complete a questionnaire in English
 ► Lives in the North West of England
 ► Severe current psychiatric disorders 
(eg, acute psychosis)
 ► Life- threatening medical illness
Group 2
Patients  ► Clinically confirmed diagnosis of epilepsy (for any duration)
 ► Any epilepsy syndrome and any types of focal or generalised 
seizures
 ► Currently being prescribed antiepileptic medication
 ► Age≥18 years (no upper age limit)
 ► Has not visited ED in the past 12 months, but has had a 
seizure with loss of awareness in this period
 ► Able to provide informed consent and independently 
complete a questionnaire in English
 ► Lives in the North West of England
 ► Severe current psychiatric disorders 
(eg, acute psychosis)
 ► Life- threatening medical illness
 ► Resides within a care or nursing home 
or has no fixed abode
Carers
 ► A significant other to a person with epilepsy (eg, family 
member, friend) who the patient identifies as providing 
informal support or self- identifies themselves if the patient 
has a substantial intellectual disability
 ► The person with epilepsy they care for has not visited ED in 
the past 12 months, but had a seizure with loss of awareness 
in this period
 ► Age≥16 years (no upper age limit)
 ► Able to provide informed consent and independently 
complete a questionnaire in English
 ► Lives in the North West of England
 ► Severe current psychiatric disorders 
(eg, acute psychosis
 ► Life- threatening medical illness
*Should recruitment prove slower than anticipated, the recruitment criteria will be relaxed to allow people who have had ED or ambulance 
contact within the last 2 years.
ED, emergency department.
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service regardless of distance, then representatives would 
be asked to what constitutes a feasible distance. Our team 
has previously used this approach.80
Recruitment
Around n=15 ambulance staff and neurology service 
representatives. Persons will be recruited from organ-
isations participating in Stage 1a with the help of a 
sampling framework to ensure representatives come from 
geographically diverse areas. Representatives will be reim-
bursed for travel. Those not able to attend will be able to 
provide feedback remotely.
Analysis
With attendees’ consent, the session will be audio- 
recorded and field notes taken. Feedback will be used to 
optimise the attribute levels within the DCEs.
stage 2
Stage 2a: developing the DCE
Purpose
Generate DCE questionnaire to elicit patient and carer 
preferences for post- seizure care and which meets best 
practice guidance.72 81
Design
A multidisciplinary panel, chaired by DAH, will compose 
a draft DCE questionnaire using Stage 1 evidence and 
refine it on the basis of a pilot. The panel will include 
expertise in DCEs (EAH), emergency medicine (SG), 
neurology (AGM), paramedical science (MJ), general 
practice (JMD) and psychology (AJN), as well as having 
service user representation.
The panel will form a consensus on which restricted 
number of ACPs best represent the range being consid-
ered and are to be valued using the DCE. Using the list 
of candidate attributes generated from Stage 1b the 
panel will select 4–6 attributes by which to describe the 
packages.
In selecting attributes, the panel will favour those prior-
itised by service users, which are modifiable, capable of 
being traded and best describe the ACPs.72 Attributes 
deemed to be too close to the latent construct of the 
utility derived from the ACP (eg, ‘satisfaction’) will not 
be selected.
DCEs will be generated for the three most common 
presentations to ED by PWE. For each, participants will 
be presented with a seizure scenario vignette and via stan-
dardised instructions complete a series of forced, pairwise 
comparisons to indicate which care packages they would 
prefer. Vignettes will be developed by the panel based on 
clinical and lived experience. Online supplementary file 
2 provides an illustration of what a DCE might look like.
Plausible attribute levels will be specified on the basis 
of findings from Stage 1, expert opinion and relevant 
literature. A strength of DCEs is the possibility of varying 
attribute levels to also model preferences within future 
contexts. Using its expertise and knowledge, the panel 
will seek to assign levels to attributes to account for major 
anticipated changes—such as longer ED waiting times.82
A fractional factorial design will identify a purposeful 
subset of options for each DCE, to allow an estimate 
of the main effect of each attribute independently and 
selected two- factor interactions, while minimising the 
number of paired comparisons participants are asked 
to make. The profiles will be obtained from a published 
design catalogue.83 Binary choices will then be created 
using the fold- over method, which replaces each attribute 
level systematically.84
Once drafted, the DCE will undergo iterative individual 
pilot testing with ~15 PWEs and carers from the project’s 
Patient and Public Involvement (PPI) group to check clarity 
and duration. Pilotees will ‘think aloud’85 when making 
choices, and asked to consider their preferred presentation 
of attributes (eg, text, pictograms). Sessions will be audio 
recorded, notes made and refinements made.
Stage 2b: formal DCE
Purpose
Determine patient and carer preferences for post- seizure 
emergency care, estimate uptake of different ACPs config-
urations, and subgroup differences.
Design
A representative sample of PWE and informal carers who 
have visited ED in the last 12 months, as well as those at 
risk, will be sought to complete the finalised DCE ques-
tionnaire. PWE who have uncontrolled epilepsy, but who 
have not visited ED in the last 12 months will be asked 
to visit an online survey page and complete the DCE 
questionnaire using their own internet enabled devices. 
Due to potentially greater social disadvantage, patients 
who have visited ED in the prior 12 months will have the 
additional option of completing the DCE during a face- 
to- face appointment with a researcher who will provide 
an internet enabled device.
To limit burden, participants will complete DCEs 
relating to just two seizure scenarios (allocated at 
random). As well as the DCEs, respondents will report 
on their demographics, epilepsy, knowledge and fear of 
seizures and service use. Each participant will receive a 
£20 shopping voucher.
Recruitment
General Practices in North- West England will identify 
potential patient participants by searching their epilepsy 
registers.86 Practices will be recruited with the help of the 
NIHR Clinical Research Network North West Coast. Prac-
tices will send ostensibly eligible patients invitation packs 
via ‘Docmail’ and a repeat invite 2 weeks later to those 
not responding. Patients not wishing to participate will be 
encouraged to notify the team and detail their reasons. 
Eligibility criteria are in table 1.
A definitive sample size calculation depends on the 
finalised design of the DCE.87 To permit decisions 
regarding recruitment to be made in the meantime 
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box 1 sample size calculation for discrete choice 
experiments
Formula used and factors considered in estimating likely 
sample size required
 ► Orme’s formulae: (n*t*a)/ c must be ≥500, where n is number of 
respondents, t number of tasks, a number of alternatives per task, 
and c number of analysis cells (for main effects, the largest number 
of levels for any one attribute).
 ► Anticipated discrete choice experiments (DCEs) to involve partici-
pants being asked to make (t) nine separate choices between (a) 
two care packages and (c) three would be maximum attribute levels. 
Thus, Orme’s formula indicated complete data from n=84 needed.
 ► Intend to complete DCEs for three different seizure scenarios, but 
participants would only complete two, therefore 126 participants 
required.
 ► To allow for variation in the finalised number of choice tasks and 
levels we increased this to 150 and further inflated it to 174 to ac-
commodate for ~15% of missing data experienced by prior epilepsy 
DCEs.
 ► As an objective was to describe and compare care preferences of 
two subgroups (patients (and associated carers) who have visited an 
ED in the prior 12 months versus patients (and associated carers) 
who have had a seizure in the prior 12 months, but have not visited 
an ED), 174 patients (and associated carers) who have visited ED in 
the prior 12 months and 174 patients (and associated carers) who 
have not, will need to be recruited.
 ► Total sample size, thus n=348.
we anticipated the design and calculated the required 
sample size by using Orme’s88 formula. Full details are 
provided in box 1. This indicated 348 PWE (or associated 
informal carers) would be required, comprising data 174 
patients (or associated carers) who have visited ED in the 
prior 12 months and 174 patients (or associated carers) 
who have not.
Based on responses to prior health DCEs89 and studies 
with PWE,16 24 we anticipate 30%–60% of those invited 
will agree to participate. An average English GP practice90 
will have 24 PWE aged ≥18 on their register who have 
experienced ≥1 seizure in the prior 12 months,9 with 10 
having visited an ED during that period.12–14 Governed 
by the need to recruit a subgroup of 174 PWE who have 
visited ED in the prior 12 months, 29–58 general prac-
tices will be required.
Analysis
Data for the different seizure vignettes will be analysed 
separately using an error components logit model that 
allows for a panel of responses from the same respon-
dent. This will determine the importance of the different 
care attributes for preference and direction of effect (as 
indicated by the significance of the coefficients and their 
size). Comparison between vignettes will depend on attri-
bute and level specification of each experiment. Analyses 
will be completed with and without respondents failing a 
‘rationality’ test.
Marginal rates of substitution (the rate at which respon-
dents are willing to give up a unit change in one attribute 
in exchange for a unit change in another while main-
taining the same level of utility) will be calculated using 
each quantitative attribute as the value attribute with 
bootstrapped confidence intervals (1000 reps).
Preference heterogeneity will be assessed by estimating 
a mixed logit model, which will include random parame-
ters for the attributes, and interactions between attributes 
and respondent characteristics.91 A- priori characteristics 
of interest are: (1) emergency care for epilepsy in the 
past 12 months (paramedic and/or ED visit), (2) social 
deprivation (with participants grouped according to how 
socially deprived the area is within which they live); (3) 
whether or not they have seen an epilepsy specialist within 
the prior 12 months (which they should have according 
to NICE guidelines88 given they will all have uncontrolled 
epilepsy); and (4) whether they or the person they know 
in the case of carers, self- reports an intellectual disability.
‘Utility scores’ for different ACP configurations and 
significantly different populations will be calculated and 
ranked accordingly. Their uptake under different seizure 
scenarios will be estimated.
All analyses will be conducted in STATA V.11.
stage 3: knowledge Exchange workshops
Purpose
Disseminate Stage 1 and 2 findings to those positioned 
to develop, fund, support and run ACPs and use their 
expertise to identify which ACP/s favoured by patients 
and carers is most NHS feasible and should be prioritised 
for implementation/evaluation.
Design
One Knowledge Exchange event in South England, one 
in the North. They will start with presentation of project’s 
findings, including ACP configurations ranked according 
to service user preference. A Nominal Group Technique, 
described by the James Lind Alliance,92 will then be 
used to hear delegates’ views of the ACPs and rank them 
according to the extent to which they meet users’ prefer-
ences and are NHS feasible. Facilitators will encourage 
delegates to consider barriers to change, supply 
constraints, acceptability of the service to staff, possible 
cost and potential to redress healthcare inequalities.
Voting will be completed using electronic devices. With 
attendees’ consent, sessions will be audio- recorded, and a 
qualitative researcher will observe and record field notes.
Recruitment
Aim to have 40–50 health service managers, commis-
sioners, healthcare professionals and service user repre-
sentatives at each event. Persons will be recruited mainly 
from the institutions participating in Stage 1a. Additional 
attendees will come from commissioning groups and 
the epilepsy patient groups. The project’s PPI group will 
also be invited. A sampling matrix will be formed to help 
ensure broadly equal representation of persons from 
health professional, commissioning and managerial roles.
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Analysis
The rank order of the ACPs that results from delegates 
voting will be described. Depending on findings from the 
previous stages, the ACPs might have been presented to 
delegates according to seizure scenario. If so, rank orders 
for the ACPs for the different scenarios will be deter-
mined and compared. As a secondary objective, rank 
orders for the different representative subgroups will be 
determined. Transcripts from the events will be themat-
ically analysed to capture delegates’ views and justifica-
tions for their preferences.
dIsCussIon
Patient and public involvement
This research was driven by a need to consider the views 
of PWE when designing an ACP for epilepsy. Epilepsy 
Action, the largest user organisation in the UK, contrib-
uted to the design of the research, and facilitated a PPI 
event with 23 service users to discuss project design and 
conduct. A PPI group will be established, including PWE 
and carers. They will be supported by Epilepsy Action 
who have an active PPI scheme and reimbursed for 
travel and time according to INVOLVE.93 The group will 
contribute as research peers by: providing feedback on 
research materials; interpretation of findings; piloting 
the DCE; and being delegates in workshops. The group 
will be encouraged to help with dissemination, including 
presenting the findings at the Stage events and teaching.
Ethics and dissemination
Monitoring by an independent Study Steering Committee 
(SSC) will help to ensure the rights, safety and well- being 
of participants are the most important considerations. Only 
persons providing informed consent will participate. The 
SSC will be composed according to our funder guidelines.94 
Compliance with the principles of Good Clinical Prac-
tice and scientific integrity will be managed by the study 
management team through regular and ad hoc meetings.
The project will identify what, if any, ACP configuration/s 
is most acceptable to service users and has the backing 
of those expected to deliver and support it. To ensure 
maximum impact those considering an ACP need to be 
aware of the project, have confidence in its outputs and use 
its findings. To help ensure this: (1) Representatives from all 
of the relevant service providers in the UK will be informed 
of the project (including notifying the leads of England’s 
Sustainability and Transformation Partnerships and Urgent 
and Emergency Care Vanguards); (2) professional bodies 
will announce its funding (Acknowledgements); (3) the 
research team includes appropriate expertise and opinion 
leaders; and (4) representatives from relevant NHS services 
will be invited to take part in Stage 1a and 3a.
The project’s findings will be disseminated via interna-
tional conferences and at least four journal manuscripts. 
The manuscripts will be published open access and non- 
technical reports will be circulated via NHS network news-
letters and Epilepsy Action. Participants will be provided 
with a copy of the results.
Having identified the ACP, funding will stop but the team 
would, via a subsequent project seek to implement and eval-
uate the chosen ACP. The nature of that evaluation will be 
informed by the state of the NHS closer to the time. The 
Medical Research Council95 highlight intervention evalua-
tion takes place in a wide range of settings and many factors 
can constrain choice of evaluation methods. One trade- off 
that may need consideration is time until results become 
available/demand versus methodological rigour.
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